Clinically, Parkinson's disease (PD) is mainly characterized by motor symptoms such as bradykinesia, rigidity, tremor, and postural instability. However, patients with PD may also experience many complaints beyond motor symptoms, which are referred to as non-motor symptoms.[@b1-jmd-4-1-33-5] The non-motor symptoms of PD are very diverse, including neuropsychiatric symptoms, sleep disturbances, sensory symptoms, and dysautonomic symptoms.[@b2-jmd-4-1-33-5] It has become increasingly apparent that non-motor symptoms have a quite considerable impact on the quality of life of PD patients.[@b1-jmd-4-1-33-5]

Impaired cardiovascular response to postural changes, particularly orthostatic hypotension (OH) is considered an important clinical and even diagnostic feature for the multiple system atrophy or pure autonomic failure.[@b3-jmd-4-1-33-5],[@b4-jmd-4-1-33-5] In PD, OH was thought to develop later in the disease course or only in more severe cases often in elderly patients.[@b5-jmd-4-1-33-5]--[@b7-jmd-4-1-33-5] Moreover, OH has been thought to be a side effect of anti-parkinsonian medications, like levodopa and dopamine agonists.[@b8-jmd-4-1-33-5]--[@b12-jmd-4-1-33-5] However, it is accepted that OH is also a common finding even in the early stages of PD.[@b13-jmd-4-1-33-5],[@b14-jmd-4-1-33-5]

The authors evaluated OH among newly-diagnosed PD patients and the relationship between OH and other symptoms of autonomic dysfunctions in patients.

Methods
=======

Subjects
--------

We studied 45 selected PD patients without dementia. The subjects had been diagnosed as PD for the first time or diagnosed as PD by other clinicians but had never been treated before. The diagnosis of PD was established according to the criteria of the United Kingdom Parkinson's Disease Society Brain Bank.[@b15-jmd-4-1-33-5] We excluded atypical or secondary parkinsonisms, and the diagnosis was confirmed during the follow up visits for more than 6 months. Comorbid medical conditions that could affect blood pressure were also evaluated, which included hypertension, diabetes mellitus, and benign prostatic hypertrophy.

Evaluation of parkinsonian symptoms
-----------------------------------

Severity and stage of parkisonism were rated using the unified Parkinson's disease rating scale, the Hoehn and Yahr stage and the Modified Schwab and England activities of daily living.

Evaluation of orthostatic hypotension and autonomic dysfunction
---------------------------------------------------------------

All patients were evaluated for the presence of OH, regardless of symptoms of orthostatic dizziness or syncope. To avoid the blood pressure lowering effect of dopaminergic drugs, all patients evaluated for OH before medication. OH was measured by monitoring systolic and diastolic blood pressure and heart rate. After a 10 minute period of lying down, systolic and diastolic blood pressures were checked in the first, third, and fifth minutes after standing up. If the patient could not stand up by his or herself, a tilt table was used. OH was defined as a drop in systolic BP ≥ 20 mmHg or diastolic BP ≥ 10 mmHg at anytime following standing up.

Comprehensive assessment of autonomic dysfunction was also assessed using a systematized autonomic dysfunction questionnaire (ADQ).[@b3-jmd-4-1-33-5] The ADQ covered gastrointestinal symptoms, urinary symptoms, sexual dysfunction, cardiovascular symptoms and thermoregulatory symptoms. The severity or frequency of each of the symptoms was expressed as scores ([Table 1](#t1-jmd-4-1-33-5){ref-type="table"}).

Statistical Analysis
====================

SPSS version 14 for Windows was used for statistical calculations. Mann-Whitney and Chi tests were employed to analyze intergroup difference. Statistical significance was declared at the *p* \< 0.05 range.

Results
=======

General and clinical characteristics of patients
------------------------------------------------

The subjects (17 men and 28 women, age of 63.8 ± 10.1 years) showed mild disease \[median Hoehn and Yahr stage 2.0 (1--3)\] with 1.3 ± 1.1 years of disease duration. Twenty-two patients had comorbid disease, which could affect blood pressure. Hypertension (20/45 patients) was the most common, followed by diabetes (7/45) and benign prostatic hyperplasia (1/45).

Eighteen patients showed OH (OH group, 8 men, age 61.3 ± 10.8 years) and twenty-seven patients (normotensive group, 9 men, age 65.5 ± 9.4 years) did not. Patients without OH were older and showed shorter duration of education, but those demographic characteristics were not significantly different between groups ([Table 2](#t2-jmd-4-1-33-5){ref-type="table"}). Parkinsonian symptoms and daily activities of the patients also showed no significant difference between groups ([Table 2](#t2-jmd-4-1-33-5){ref-type="table"}).

Symptoms of autonomic dysfunctions in patients
----------------------------------------------

Many dysautonomic symptoms were accompanied with OH in patients, and all the patients had more than two of those symptoms ([Table 3](#t3-jmd-4-1-33-5){ref-type="table"}). Urinary symptoms were most common and followed by sexual symptoms. Although urinary incontinence was more prevalence in OH group, it did not reach statistical significance. The presence of OH was not related with the presence of other symptoms.

Total score in the ADQ was slightly increased in patients with OH compared to that of patients without OH ([Table 4](#t4-jmd-4-1-33-5){ref-type="table"}). However, the differences did not reach statistical significance. In spite of the insignificant difference, the scores of all domains in the OH group were higher than those of the normotensive group. However, even in the questions of cardiovascular symptoms, orthostatic dizziness and history of syncope, there was no difference between groups. Only eight patients complained of orthostatic dizziness and four of those patients showed OH.

Discussion
==========

Abnormal cardiovascular regulation, including orthostatic hypotension was frequently expressed in various stages of PD patients.[@b16-jmd-4-1-33-5],[@b17-jmd-4-1-33-5] The cardiovascular autonomic disturbances are following the gastrointestinal symptoms in frequency, but they have a higher impact on the quality of life in PD patients.

Lewy bodies, a pathological hallmark of Parkinson's disease, have been found in autonomic regulatory regions of the brain or peripheral autonomic ganglia in PD patients.[@b18-jmd-4-1-33-5] And, many studies have shown the evidence of cardiac sympathetic denervation in early PD patients by using cardiac sympathetic imaging.[@b19-jmd-4-1-33-5],[@b20-jmd-4-1-33-5]

Symptoms of autonomic dysfunction in PD patients were known to be related with older age, long disease duration, severe disease stage and anti-parkinsonian medication.[@b7-jmd-4-1-33-5] However, Allcock et al. showed that frequency of OH was independent of duration and severity of movement symptoms in the study of the frequency of OH in a community-based cohort of PD patients.[@b13-jmd-4-1-33-5] The prevalence of OH in PD was variable according to criteria and methods. In 5 relatively large studies involving more than 80 patients each, the frequency of OH ranged from 30% to 58%.[@b6-jmd-4-1-33-5] Bonuccelli et al.[@b21-jmd-4-1-33-5] showed the high prevalence of OH in de novo PD patients. In our study, prevalence of OH in the drug-naïve PD patients was moderate (18/45 patients, 40%), and similarly shown in the patients without comorbid disease (9/23 patient, 39.1%). Patients with OH were young and showed a short duration of disease, but those differences did not reach statistical significance, and the severity of parkinsonian symptoms was similar to those of patients without OH. The presence or severity of dysautonomic symptoms was not different between patients with or without OH, even in the cardiovascular domain. Therefore, OH did not respect the severity or distribution of other autonomic symptoms. Actually, the complaint of orthostasis was made by only six patients (13.3%), four of those patients showed OH. Most patients with OH did not complain of orthostasis, and Steven et al. showed that the majority of patients with profound orthostatic hypotension either did not show the typical symptoms (33%), or showed only atypical symptoms (24%).[@b22-jmd-4-1-33-5] The unawareness of orthostatic hypotension stresses the importance of blood pressure monitoring irrelevant to complaints of patients.

Although we could not find statistical significance, patients with urinary incontinence were much higher in OH group (27.8% vs. 7.4%). This finding suggests that those patients can be diagnosed as multiple system atrophy (MSA). We followed all the patients more than six months and confirmed the good response to dopaminergic treatment. Because some patients with MSA show good response to treatment in early period, we could not exclude the possibility of MSA. Further studies with longer period of observation and about the change of dysautonomic symptoms along the disease course are warranted.

Although pathological implications of autonomic dysfunctions in PD patients have not been established yet, clinical implications can be significant enough to impact the daily activities of PD patients. Furthermore, most patients do not complain of noticeable symptoms, and the unawareness of patients warrants careful evaluation. Appropriate management of OH can prevent further insult and can improve daily activities of PD patients.

The author has no financial conflicts of interest.

###### 

Autonomic dysfunction questionnaire

  Gastrointestinal symptoms          Urinary symptoms       Sexual dysfunction       Cardiovascular symptoms   Thermoregulatory symptoms
  ---------------------------------- ---------------------- ------------------------ ------------------------- ---------------------------
  Salivation                         Hesitancy              Erectile dysfunction     Orthostasis               Sweating (Face)
  Dysphagia                          Urgency                Ejaculation difficulty   Syncope                   Sweating (Trunk)
  Nausea                             Incomplete voiding     Libido change                                      Sweating (Limb)
  Constipation                       Weak stream                                                               Heat intolerance
  Defecatory dysfunction (anismus)   Frequency                                                                 Cold intolerance
                                     Nocturia                                                                  Oiliness & seborrhea
                                     Urinary incontinence                                                      

###### 

Demographic & parkinsonian features in each group

  Group                       Patients with orthostatic hypotension (*n* = 18)   Patients without orthostatic hypotension (*n* = 27)   *p*
  --------------------------- -------------------------------------------------- ----------------------------------------------------- -----
  Sex (M : F)                 8 : 10                                             9 : 18                                                NS
  Age (Y)                     61.3 ± 10.8                                        65.5 ± 9.4                                            NS
  Duration of symptoms (M)    13.8 ± 10.1                                        16.1 ± 15.9                                           NS
  Duration of education (y)   8.0 ± 3.9                                          5.9 ± 4.6                                             NS
  Comorbid disorders          9 (50.0%)                                          13 (48.1%)                                            NS
  UPDRS Part I                2.7 ± 1.5                                          2.4 ± 1.5                                             NS
  UPDRS Part II               9.0 ± 4.5                                          9.1 ± 3.7                                             NS
  UPDRS Part III              24.3 ± 7.7                                         26.5 ± 8.9                                            NS
  UPDRS total                 36.7 ± 10.5                                        38.2 ± 11.8                                           NS
  Hoehn & yahr stage          2.0 ± 0.6                                          2.0 ± 0.5                                             NS
  SEADL                       73.3 ± 11.5                                        75.4 ± 11.2                                           NS

K-MMSE: Korean version of mini-mental status exam, ADL: activity of daily living, SEADL: schwab and england activity of daily living

###### 

Presence of dysautonomic symptoms in each group

                                                                         Patients with orthostatic hypotension (*n* = 18)   Patients without orthostatic hypotension (*n* = 27)   *p*
  ---------------------------------------------------------------------- -------------------------------------------------- ----------------------------------------------------- -----
  Gastrointestinal symptom                                                                                                                                                        
   Salivation                                                            27.8% (5)                                          25.9% (7)                                             NS
   Dysphagia                                                             11.1% (2)                                          14.8% (4)                                             NS
   Nausea                                                                22.2% (4)                                          25.9% (7)                                             NS
   Constipation                                                          44.4% (8)                                          25.9% (7)                                             NS
   Anismus                                                               27.8% (5)                                          11.1% (3)                                             NS
  Urinary symptom                                                                                                                                                                 
   Hesitancy                                                             33.3% (6)                                          29.6% (8)                                             NS
   Urgency                                                               27.8% (5)                                          33.3% (9)                                             NS
   Incomplete voiding                                                    38.9% (7)                                          44.4% (12)                                            NS
   Weak stream                                                           38.9% (7)                                          33.3% (9)                                             NS
   Frequency                                                             77.8% (14)                                         66.7% (18)                                            NS
   Nocturia                                                              72.2% (13)                                         74.1% (20)                                            NS
   Incontinence                                                          27.8% (5)                                          7.4% (2)                                              NS
  Sexual dysfunction                                                                                                                                                              
   Erectile dysfunction[\*](#tfn2-jmd-4-1-33-5){ref-type="table-fn"}     37.5% (3/8)                                        22.2% (2/9)                                           NS
   Ejaculation difficulty[\*](#tfn2-jmd-4-1-33-5){ref-type="table-fn"}   37.5% (3/8)                                        33.3% (3/9)                                           NS
   Change of libido                                                      50.0% (9)                                          40.7% (11)                                            NS
  Cardiovascular symptom                                                                                                                                                          
   Orthostasis                                                           22.2% (4)                                          7.4% (2)                                              NS
   Syncope                                                               11.1% (2)                                          0.0% (0)                                              NS
  Thermoregulatory symptom                                                                                                                                                        
   Sweat                                                                 11.1% (2)                                          11.1% (3)                                             NS
   Heat intolerance                                                      11.1% (2)                                          11.1% (3)                                             NS
   Cold intolerance                                                      5.6% (1)                                           0.0% (0)                                              NS
   Oiliness of skin                                                      11.1% (2)                                          0.0% (0)                                              NS

evaluated male patients only

###### 

Severity of dysautonomic symptoms in each group

                             Patients with orthostatic hypotension (*n* = 18)   Patients without orthostatic hypotension (*n* = 27)   *p*
  -------------------------- -------------------------------------------------- ----------------------------------------------------- -----
  Gastrointestinal symptom                                                                                                            
   Salivation                0.2 ± 0.4                                          0.4 ± 0.4                                             NS
   Dysphagia                 0.2 ± 0.5                                          0.2 ± 0.7                                             NS
   Nausea                    0.2 ± 0.4                                          0.3 ± 0.5                                             NS
   Constipation              0.8 ± 1.1                                          0.2 ± 0.4                                             NS
   Anismus                   0.5 ± 0.9                                          0.2 ± 0.5                                             NS
   Sum                       2.1 ± 2.7                                          1.4 ± 1.8                                             NS
  Urinary symptom                                                                                                                     
   Hesitancy                 0.6 ± 1.2                                          1.0 ± 1.6                                             NS
   Urgency                   0.6 ± 1.2                                          0.8 ± 1.4                                             NS
   Incomplete voiding        1.1 ± 1.9                                          1.2 ± 1.6                                             NS
   Weak stream               1.2 ± 1.9                                          1.2 ± 1.2                                             NS
   Frequency                 1.7 ± 1.8                                          1.5 ± 1.4                                             NS
   Nocturia                  1.8 ± 1.5                                          1.5 ± 0.9                                             NS
   Incontinence              0.5 ± 0.8                                          0.1 ± 0.4                                             NS
   Sum                       7.7 ± 7.9                                          7.2 ± 6.5                                             NS
  Sexual dysfunction                                                                                                                  
   Erectile dysfunction      0.6 ± 1.4                                          0.3 ± 0.9                                             NS
   Ejaculation difficulty    0.6 ± 1.5                                          0.4 ± 1.0                                             NS
   Change of libido          1.8 ± 1.9                                          1.4 ± 1.8                                             NS
   Sum                       3.2 ± 4.2                                          2.3 ± 3.4                                             NS
  Cardiovascular symptom                                                                                                              
   Orthostasis               0.5 ± 0.9                                          0.1 ± 0.3                                             NS
   Syncope                   0.0 ± 0.0                                          0.0 ± 0.0                                             NS
   Sum                       0.8 ± 1.5                                          0.2 ± 0.5                                             NS
  Thermoregulatory symptom                                                                                                            
   Sweat                     0.4 ± 1.0                                          0.0 ± 0.0                                             NS
   Heat intolerance          0.1 ± 0.3                                          0.2 ± 0.6                                             NS
   Cold intolerance          0.4 ± 1.0                                          0.0 ± 0.0                                             NS
   Oiliness of skin          0.1 ± 0.3                                          0.0 ± 0.0                                             NS
   Sum                       1.1 ± 2.6                                          0.8 ± 2.2                                             NS
  Total score                15.0 ± 15.4                                        11.7 ± 9.5                                            NS
